Use of Direct Oral Anticoagulants Following Cardiac Implantable Electronic Device Placement

  • 0Division of Cardiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.

|

|

Summary

This summary is machine-generated.

Direct oral anticoagulants (DOACs) were prescribed to over half of atrial fibrillation (AF) patients after cardiac implantable electronic device (CIED) placement, with increasing use over time. While DOAC use showed slightly higher hematoma risk, it was associated with reduced stroke rates.

Area Of Science

  • Cardiology
  • Pharmacology

Background

  • Limited data exists on direct oral anticoagulant (DOAC) use in atrial fibrillation (AF) patients undergoing cardiac implantable electronic device (CIED) placement.
  • Real-world practice patterns and outcomes of uninterrupted DOAC therapy in this population are not well-defined.

Purpose Of The Study

  • To describe trends in DOAC usage after uncomplicated, outpatient CIED implantation in AF patients.
  • To evaluate clinical outcomes associated with DOAC status at discharge.

Main Methods

  • Utilized National Cardiovascular Data Registry data for AF patients (CHA <sub>2</sub> DS <sub>2</sub> -VASc ≥ 2) undergoing uncomplicated, outpatient CIED placement (April 2016-December 2019).
  • Stratified patients by DOAC prescription at discharge and assessed outcomes using Centers for Medicare and Medicaid (CMS) claims data.

Main Results

  • 54.1% of 59,169 eligible AF patients were discharged on a DOAC, with annual discharge rates increasing from 47.0% (2016) to 62.5% (2019).
  • DOAC use was associated with higher adjusted rates of pocket hematoma (0.51% vs. 0.33%) and lower rates of stroke (2.9% vs. 3.2%) at 30 days.
  • No significant differences in device infection or revision rates at 30 days or 1 year were observed between groups.

Conclusions

  • Approximately half of AF patients undergoing CIED implantation were discharged on DOACs, with increasing trends observed.
  • DOAC use was linked to a modest increase in pocket hematoma and device revision rates but a similar risk of device infection.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants 01:18

1.3K

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Anticoagulant Drugs: Low-Molecular-Weight Heparins 01:30

911

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Venous Thrombosis III: Interprofessional Care 01:29

22

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Cardiac Catheterization IV: Nursing Management 01:26

193

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...

Cardiac Catheterization I: Pre-Procedure Overview 01:28

160

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...

Cardiomyopathy V: Interprofessional Care 01:29

34

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...